Heart Failure Patients Registry

CompletedOBSERVATIONAL
Enrollment

19,990

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Heart Failure
Trial Locations (65)

Unknown

Research Site, Akhtubinsk

Research Site, Stary Oskol

Research Site, Gurievsk

Research Site, Rodniki Settlement

Research Site, Korolyov

Research Site, Lyubertsy

Research Site, Pushchino

Research Site, Bor

Research Site, Beslan

Research Site, Zubova Polyana Settlement

Research Site, Aramil

Research Site, Arkhangelsk

Research Site, Astrakhan

Research Site, Barnaul

Research Site, Bataysk

Research Site, Belgorod

Research Site, Bryansk

Research Site, Cheboksary

Research Site, Chelyabinsk

Research Site, Irkutsk

Research Site, Izhevsk

Research Site, Kaluga

Research Site, Kazan'

Research Site, Kemerovo

Research Site, Khabarovsk

Research Site, Khanty-Mansiysk

Research Site, Kirov

Research Site, Kostroma

Research Site, Krasnodar

Research Site, Krasnoyarsk

Research Site, Kursk

Research Site, Lipetsk

Research Site, Makhachkala

Research Site, Moscow

Research Site, Nizhny Novgorod

Research Site, Novosibirsk

Research Site, Omsk

Research Site, Orenburg

Research Site, Oryol

Research Site, Penza

Research Site, Perm

Research Site, Petrozavodsk

Research Site, Rostov-on-Don

Research Site, Ryazan

Research Site, Saint Petersburg

Research Site, Samara

Research Site, Saratov

Research Site, Smolensk

Research Site, Stavropol

Research Site, Surgut

Research Site, Syktyvkar

Research Site, Tambov

Research Site, Tula

Research Site, Tver'

Research Site, Tyumen

Research Site, Ufa

Research Site, Ulan-Ude

Research Site, Ulyanovsk

Research Site, Vladimir

Research Site, Vladivostok

Research Site, Volgograd

Research Site, Voronezh

Research Site, Yaroslavl

Research Site, Yekaterinburg

Research Site, Yoshkar-Ola

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY